US FDA stops notarizing device export certificates
This article was originally published in Clinica
The US FDA has discontinued its practice of notarizing medical device export certificates and manufacturers will now have to apply to another government department for the authentication. At the same time, the agency is enhancing its voluntary online system for allowing manufacturers to request export documents more efficiently than submitting their applications on paper.
You may also be interested in...
FDA plans to make major changes to the CDRH Export Certification and Tracking System that allows companies to process export submissions electronically. The agency will be holding a webinar in mid-September to prepare stakeholders.
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.